Mounjaro Demonstrates Sustained Weight Loss Over 3 Years, Long-Term Study Confirms

Mounjaro Supports Long-Term Weight Management

Image credit: NurPhoto/Getty Images
A recent study presented at the European Congress on Obesity (ECO) in Malaga, Spain, reveals that a once-weekly dose of tirzepatide (Mounjaro) can lead to significant and durable weight loss lasting up to three years in adults with overweight or obesity who do not have diabetes.
Key Findings:
- The treatment resulted in sustained weight reduction across a three-year period.
- Response to therapy varies by sex and presence of obesity-related health issues.
- Researchers identified three distinct weight loss patterns among participants.
Study Details:
The study involved 700 participants, primarily women, with an average age of 48 years, all of whom were either living with obesity or overweight and had prediabetes. Participants were grouped based on their weight loss trajectories:
- Group 1 (248 people): Steady loss (~10%), plateaued early.
- Group 2 (226 people): Rapid initial loss (~20%), plateaued later.
- Group 3 (226 people): Largest loss (~30%), longest time to plateau.
Insights into Weight Loss and Plateaus:
While weight loss plateaus are natural due to body mechanisms, most participants maintained significant weight reduction. The study highlights that even modest weight loss (5%) improves health markers, and greater losses (15%) yield more substantial benefits.
Expert Opinions:
Medical professionals acknowledge tirzepatide's effectiveness but emphasize the importance of ongoing support and patient education to sustain benefits. Variability in individual response underscores the need for personalized treatment plans.
Conclusion:
The findings support the use of tirzepatide as a long-term weight management tool and indicate that personalized strategies could enhance outcomes. Safety profile remains consistent with common side effects including nausea, diarrhea, and constipation.
For more insights, visit the European Congress on Obesity website or consult healthcare professionals familiar with this therapy.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Q&A: Debunking 8 Common Myths About Back Pain
Learn the facts behind common misconceptions about back pain, including causes, treatments, and prevention tips to help you manage and protect your spinal health.
Innovative Immunotherapy Approach for Alzheimer's Inspired by Cancer Treatments
Discover how cutting-edge immunotherapy technology, originally developed for cancer, is now being adapted to target Alzheimer's disease by engineering immune cells that recognize toxic protein accumulations in the brain.
Internationally Recognized Curriculum Launched to Standardize Epilepsy Surgery Training
The ILAE has developed the first international curriculum to standardize epilepsy surgery training, aiming to improve epilepsy care globally. This comprehensive program addresses training gaps and promotes high-quality surgical practices.
RFK Jr. Questions Rising Autism Rates: Experts Caution About Oversimplified Explanations
Amid recent political discussions, experts highlight that broader diagnostic criteria and increased awareness largely explain rising autism rates, urging cautious interpretation and continued research.



